The 2020 Gastrointestinal Cancers Symposium took place last weekend, and today, we’ll take a deeper dive into findings in pancreatic cancer and colorectal cancer. We’ll also review the FDA approval of tazemetostat in epithelioid sarcoma.

Coverage of stories discussed this week on ascopost.com:

‘Unprecedented’ Responses to Cisplatin/Gemcitabine in BRCA-Mutated Advanced Pancreatic Cancer

FDA Approves Tazemetostat for Epithelioid Sarcoma